Julie Grenier joined Certara in March 2018 as a quantitative clinical pharmacologist, supporting an integrated drug development approach for our client base. Julie has almost 20 years of drug development experience with a focus in pharmacokinetics, pharmacodynamics, and clinical pharmacology study design, analysis, and interpretation. Before joining Certara, Julie was an Associate Director of Clinical Pharmacology at Celerion, where she led a multidisciplinary team of scientists focused predominantly on drug-drug interaction, bioavailability and bioequivalence, first-in-human, hepatic, and renal impairment, human mass balance, and cardiac liability assessments. Throughout the years, Julie has overseen dozens of studies from protocol development to final clinical study reports. Julie has experience in pharmacometrics and earned her PhD in modeling and simulation (Pharmaceutical Science) from University of Montreal.